While the orthopedic biomaterials market was the biggest segment in 2008 with $9.8 billion, the cardiovascular biomaterial market is estimated to be dominant segment in 2014 with an estimated $20.7 billion. The cardiovascular biomaterial market is expected to grow with a CAGR of 14.5% from 2009 to 2014 mainly due to increasing stress levels that have in turn increased the incidence of cardiac arrest.
The U.S. market is the largest geographical segment for biomaterials; and is expected to be worth $22.8 billion by 2014 with a CAGR of 13.6% from 2009 to 2014. Europe is the second largest segment and is expected to reach $17.7 billion by 2014 with a CAGR of 14.6% and the Asian market size is estimated to increase at the highest CAGR of 18.2% from the year 2009 to 2014.
This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:
Biomaterials product market
Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological surgery, and others
Biomaterials ingredient market
Metals, polymers, ceramics, composites
Biomaterials application market
General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications
Analyst Briefings on 16th Sep 2009.
The Biotech practice at MarketsandMarkets is pleased to announce its
Analyst Briefing Presentation on the Global Biomaterial market to be held on
16th Sep 2009. The briefing on the Global Biomaterial Market (2009-2014) will
benefit the biotech component manufacturers, biomaterial device
manufacturers, medical/pharma associations, pharma research labs, Doctors,
physician and hospitals, technology provid
|SOURCE Markets and Markets|
Copyright©2009 PR Newswire.
All rights reserved